We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Baucus Proposal Keeps Industry Fees, Comparative Effectiveness Research
Baucus Proposal Keeps Industry Fees, Comparative Effectiveness Research
September 18, 2009
Brand drugmakers probably will face the highest fees under a $2.3 billion annual program in Sen. Max Baucus’ (D-Mont.) legislation for healthcare overhaul, an expert says, but they could offset the effect by raising prices.